Bristol Myers Squibb (CELG-RI) Profit After Tax (2009 - 2026)

Bristol Myers Squibb has disclosed Profit After Tax across 18 years of filings, most recently posting $2.7 billion for Q1 2026.

• In Q1 2026, Profit After Tax rose 8.77% year-over-year to $2.7 billion; the TTM figure through Mar 2026 stood at $6.0 billion (up 10.1% YoY), while the FY2025 annual figure was $7.1 billion, up 178.83% from the prior year.
• Profit After Tax advanced to $2.7 billion in Q1 2026, from $1.1 billion in the prior quarter.
• Over the last five years, Profit After Tax for CELG-RI reached as high as $2.7 billion in Q1 2026 and fell as low as -$11.9 billion in Q1 2024.
• The 5-year median for Profit After Tax is $1.4 billion (2022), against an average of $485.4 million.
• The widest YoY moves for Profit After Tax: up 41900.0% in 2024, down 238320.0% in 2024.
• A 5-year view of Profit After Tax shows it stood at $2.0 billion in 2022, then slipped by 13.63% to $1.8 billion in 2023, then slumped by 96.54% to $61.0 million in 2024, then surged by 1677.05% to $1.1 billion in 2025, then soared by 147.05% to $2.7 billion in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered $2.7 billion, $1.1 billion, and $2.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.